Medical Device Recall: Guardian 4 Glucose Sensor Manufacturing Defect
Medtronic is recalling Guardian 4 Glucose Sensors due to manufacturing defects in the glucose oxidase layer. Defects may cause sensors to malfunction or provide inaccurate readings, potentially affecting insulin dosing.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of a risk-of-harm medical device (continuous glucose monitor). No hospitalizations or injuries reported, but the identified manufacturing defect creates genuine risk for serious medical consequences: sensor malfunction could lead to inaccurate glucose readings and improper insulin dosing, potentially causing hyperglycemia or hypoglycemia. Meets the rubric criterion for High severity.
Plain-English summary
Medtronic MiniMed, Inc. is recalling Guardian 4 Glucose Sensors due to a manufacturing defect affecting the glucose oxidase (GOX) layer. The GOX layer thickness in some affected sensors falls outside the specification range of 5.5 to 9.2 micrometers.
The affected sensors include reference numbers MMT-7040A, MMT-7040C1, MMT-7040C2, MMT-7040C3, MMT-7040D1, MMT-7040D2, MMT-7040MA, MMT-7040QC1, MMT-7040QC2, and MMT-7040QC3, with specific lot codes identified by Medtronic. Approximately 114,758 units are affected, distributed worldwide including throughout the United States and multiple international countries.
When the GOX layer is too thin, it can impair sensor function or result in complete loss of function. This may cause the sensor to provide inaccurate glucose readings. If glucose readings are affected, users may receive incorrect insulin dosing recommendations, potentially resulting in too little insulin (hyperglycemia) or too much insulin (hypoglycemia). The impact ranges from user inconvenience to serious medical consequences depending on the extent of malfunction.
Patients using Guardian 4 Glucose Sensors should check their device reference number and lot code against the recall notification. Individuals with affected devices should contact their healthcare provider or Medtronic for guidance on device replacement or continued use.
The recalled product
- Product
- Guardian 4 Glucose Sensor, REF: MMT-7040A, MMT-7040C1, MMT-7040C2, MMT-7040C3, MMT-7040D1, MMT-7040D2, MMT-7040MA, MMT-7040QC1, MMT-7040QC2, MMT-7040QC3
- Manufacturer
- Medtronic MiniMed, Inc.
- Affected units
- 114,758
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- REF/UDI-DI/Lot: MMT-7040A/20763000413389/HG72B2C
- HG72CQQ
- HG73VB7
- HG73VC8
- HG73VFT
- HG73WFR
- HG7441E
- HG745F9
- HG7486X
- HG74AJ1
- HG74SUR
- HG74T9Q
- HG74U36
- HG78LMS
- HG79Y9U
- MMT-7040C1/00763000555276
- 00763000413392
- 20763000413396
- 20763000555270
- 20763000712475
Distribution
Related recalls
Same manufacturer · Medtronic MiniMed, Inc.
See all →- HighMedtronic MiniMed 780G Insulin Pumps Recalled for Chemical Damage Risk
FDA (Devices) · 2026-08-26
- HighMedtronic MiniMed 640G Insulin Pumps Recalled for Chemical Damage Risk
FDA (Devices) · 2026-08-26
- SevereMedtronic MiniMed 670G Insulin Pumps Recalled Due to Chemical Damage Risk
FDA (Devices) · 2026-08-26
- HighMiniMed Go App Recalled Due to Missed Insulin Alerts
FDA (Devices) · 2026-07-29
- HighMiniMed 780G Insulin Pump Software Anomaly Recall
FDA (Devices) · 2026-07-15
Same hazard · sensor malfunction
See all →- ModeratePhotera 600 3-D phototherapy device UV sensor calibration error recall
FDA (Devices) · 2026-07-22
- ModeratePhotera 600 Phototherapy Device UV Sensor Calibration Error
FDA (Devices) · 2026-07-22
- SevereiLet Bionic Pancreas Software Versions Recalled for Delayed CGM Readings
FDA (Devices) · 2026-05-06
- SevereAbiomed Impella RP with SmartAssist recalled as Class I
FDA (Devices) · 2026-03-11
- SevereAbiomed Impella RP recalled as Class I over sensor malfunction risk
FDA (Devices) · 2026-03-11